These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6405376)

  • 1. [Viability of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Isaeva ZhN
    Probl Tuberk; 1983 Feb; (2):59-64. PubMed ID: 6405376
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA
    Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic importance of the quantitative determination of the extent of bacteria excretion during the chemotherapy process in chronic destructive pulmonary tuberculosis].
    Khomenko AG; Kozulitsyna TI; Kaminskaia AA; Andrusskaia MK; Khlopovskiĭ SG
    Probl Tuberk; 1981 Jun; (6):17-22. PubMed ID: 7024984
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of the bacteriological study of the associated bacterial flora of the sputum of patients with chronic pulmonary tuberculosis].
    Boccitto G; Salvati F; De Ritis G
    Policlinico Prat; 1970 Apr; 77(15):477-89. PubMed ID: 4987995
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Kaminskaia AA; Abdullaeva ET
    Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM; Iarygina IV
    Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of bacterioscopic and bacteriological methods for detecting bacterial excretion in newly diagnosed patients with destructive pulmonary tuberculosis].
    Roslik SM; Pashkov IuN; Pospelov VV; Pavlova GB; Starova MK
    Lab Delo; 1986; (5):298-300. PubMed ID: 2425141
    [No Abstract]   [Full Text] [Related]  

  • 9. [Further study on the decontaminated pretreatment of Mycobacterium tuberculosis cultures].
    Wong H
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Oct; 9(5):264-6, 317. PubMed ID: 3100256
    [No Abstract]   [Full Text] [Related]  

  • 10. [New criteria for discharge from ward in patients with pulmonary tuberculosis using mycobacteria growth indicator tube].
    Fujino M; Kishi F; Akiyama Y; Ogasawara H; Matsumoto H
    Kekkaku; 2007 Jan; 82(1):11-7. PubMed ID: 17310777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycobacterium tuberculosis L forms in patients with abacillary lung caverns].
    Berezovskiĭ BA; Golanov VS
    Probl Tuberk; 1981 Jun; (6):22-5. PubMed ID: 6792625
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical value of Mycobacterium tuberculosis with different biological properties].
    Vishnevskiĭ BI; Ivanova LA; Kolechko NG; Kochanova NK; Makovskaia GM
    Probl Tuberk; 1991; (4):51-4. PubMed ID: 1906617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of finding mycobacterial L forms in patients with destructive pulmonary tuberculosis].
    Golanov VS
    Probl Tuberk; 1986; (9):25-8. PubMed ID: 3097630
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical picture and course of chronic destructive pulmonary tuberculosis in patients secreting L forms of the causative agent].
    Karachunskiĭ MA; Dorozhkova IR; Abdullaeva ET
    Probl Tuberk; 1985; (12):13-6. PubMed ID: 3938018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence and clinical significance of visible but not viable bacilli in patients with pulmonary tuberculosis].
    Krychniak W; Araszkiewicz W; Zych D; Janowiec M; Pelczarska B
    Gruzlica; 1975 Sep; 43(9):785-92. PubMed ID: 808444
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of bacteriological method for the diagnosis of tuberculosis in non-transportable patients with chronic generalized diseases].
    Dukarskiĭ BG; Edel'shteĭn LL; Andreeva TT; Batutin VI; Bystrova ZN
    Probl Tuberk; 1981 Mar; (3):12-4. PubMed ID: 6453338
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonculturable acid-fast forms in the sputum of patients with tuberculosis and chronic pulmonary disease.
    Warring FC; Sutramongkole U
    Am Rev Respir Dis; 1970 Nov; 102(5):714-24. PubMed ID: 4097642
    [No Abstract]   [Full Text] [Related]  

  • 19. [Method of treatment of sputum for optimal growth of Mycobacterium tuberculosis (II)].
    Liapunova AD; Pashkov IuN; Presman TP; Chaĭkina TN; Brilliantova SA
    Lab Delo; 1983; (2):39-41. PubMed ID: 6187981
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of a modified Löwenstein-Jensen medium for the isolation of Mycobacterium tuberculosis from pathological material].
    Sosnovskaia-Martynova AV; Puĭshene IP
    Probl Tuberk; 1973; 51(10):80-2. PubMed ID: 4206104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.